A million Swedish crones for medical development projects in Göteborg

Altogether around 50 applications were received, and among the seven chosen to share the grant money is GraftCraft, owned by the research scientists Erney Mattsson and Torbjörn Lundh. GraftCraft´s research is aimed at developing initial treatment for arterial aneurysms.

"This grant makes it possible to continue development of the company´s product and prepare it for commercialisation," say Mattson and Lundh.

GraftCraft has two more medical projects in its portfolio, and one of them involves a new vascular graft that bears the working name "Little Y". These two projects will undergo further development during the year, and preparations are in place for the company to outsource its future production to an established unit inWestern Sweden .

The other six research projects are focused on the following specialist fields:

Immune blockade of autoimmune diseases
Ortoma — the intervertebral disc prosthesis of the future
Interdisciplinary cooperation to solve absorption problems with promising substances in oncology
Verification of a hyperthermal microwave system
Treatment of advanced renal cancer with NC001
PORENIX — nanotechnology for advanced filtration and bioseparation

-------------------------------------------------------------------------------------------------------- Sahlgrenska SciencePark strives to ensure a powerful biomedical innovation system inWestern Swedenby promoting the commercialisation of research-based innovations and the development of business projects and companies in medical areas of application.
 
GöteborgBIO is a cooperation project between national and regional organisations aimed at creating a sound basis for long-term growth in the area of biomedicine in the region by turning leading-edge academic research into innovations in industry and applications in healthcare. The organisations involved  are AstraZeneca, Business Region Göteborg, Chalmers, the UniversityofGothenburg, Innovationsbron Väst, Mölnlycke Health Care, Nobel Biocare and Västra Götaland Region . Financial and operational support is obtained from Vinnova (the Swedish Agency for Innovation Systems) through the Vinnväxt programme.
 
For further information, please contact: Gunilla Bökmark, CEO of SahlgrenskaSciencePark, +46 (0)31- 741 17 07, gunilla.bokmark@sahlgrenskasciencepark.se